We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.04B
AUM Growth
-$14.7M
Cap. Flow
-$95.6M
Cap. Flow %
-9.17%
Top 10 Hldgs %
20.32%
Holding
1,067
New
108
Increased
299
Reduced
450
Closed
137

Top Buys

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$7.89M
2
NDMO icon
Nuveen Dynamic Municipal Opportunities Fund
NDMO
+$5.1M
3
GLD icon
SPDR Gold Trust
GLD
+$3.32M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.53M
5
TSLA icon
Tesla
TSLA
+$1.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.5M
2
LULU icon
lululemon athletica
LULU
+$5.75M
3
AMZN icon
Amazon
AMZN
+$4.19M
4
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$3.75M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Healthcare 9.62%
3 Consumer Discretionary 9.35%
4 Financials 7.91%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAGX icon
901
Jaguar Health
JAGX
$4.75M
– –
0
– –
ARMP icon
902
Armata Pharmaceuticals
ARMP
$173M
$32K ﹤0.01%
+10,103
New +$35.5K
CLSD
903
DELISTED
Clearside Biomedical
CLSD
$32K ﹤0.01%
1,393
-134
-9% -$3.46K
DSWL icon
904
Deswell Industries
DSWL
$54.5M
$30K ﹤0.01%
11,100
– –
OXSQ icon
905
Oxford Square Capital
OXSQ
$147M
$30K ﹤0.01%
12,100
-500
-4% -$1.34K
PVLA
906
Palvella Therapeutics
PVLA
$1.99B
$30K ﹤0.01%
+183
New +$41.7K
AKBA icon
907
Akebia Therapeutics
AKBA
$333M
$29K ﹤0.01%
+11,500
New +$101K
QCLS
908
Q/C Technologies Inc
QCLS
$23.9M
$29K ﹤0.01%
+2
New +$47.4K
AIM
909
AIM ImmunoTech
AIM
$6.65M
$29K ﹤0.01%
+133
New +$33.2K
TXMD icon
910
TherapeuticsMD
TXMD
$23.6M
$28K ﹤0.01%
360
-120
-25% -$9.56K
CSCI
911
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$28K ﹤0.01%
794
+594
+297% +$26.3K
BNGO icon
912
Bionano Genomics
BNGO
$12.5M
$26K ﹤0.01%
+67
New +$26K
BDRX
913
Biodexa Pharmaceuticals
BDRX
$1.36M
– –
0
– –
TPST icon
914
Tempest Therapeutics
TPST
$14.5M
$23K ﹤0.01%
74
-3
-4% -$1.02K
MNKD icon
915
MannKind Corp
MNKD
$1.2B
$22K ﹤0.01%
11,500
-900
-7% -$1.56K
MUX icon
916
McEwen Inc
MUX
$1.02B
$21K ﹤0.01%
2,000
+980
+96% +$11.9K
XYLO
917
DELISTED
Xylo Technologies
XYLO
$20K ﹤0.01%
355
-295
-45% -$17.6K
CRIS icon
918
Curis
CRIS
$9.28M
$18K ﹤0.01%
+38
New +$17.9K
OGI
919
Organigram Holdings
OGI
$133M
$18K ﹤0.01%
4,300
-100
-2% -$521
WPG
920
DELISTED
Washington Prime Group Inc.
WPG
$16K ﹤0.01%
2,766
-361
-12% -$2.31K
ITRM
921
DELISTED
Iterum Therapeutics
ITRM
$12K ﹤0.01%
+791
New +$10.6K
SCPX
922
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
NBRV
923
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$11K ﹤0.01%
84
– –
ACOR
924
DELISTED
Acorda Therapeutics
ACOR
$8K ﹤0.01%
126
-82
-39% -$6.18K
ELGX
925
DELISTED
Endologix Inc
ELGX
$4K ﹤0.01%
140,600
+106,400
+311% +$41.3K
35 36
37
38 39

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Wedbush Securities held 1,067 positions worth $1.04B, down 1.4% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Wedbush Securities withdrew a net $95.6M in Q3 2020, closing 137 positions and reducing 450 holdings. Its most notable exit was Invesco KBW High Dividend Yield Financial ETF, an estimated $810K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Wedbush Securities opened a new position in Nuveen Dynamic Municipal Opportunities Fund worth $5.08M.

  • Wedbush Securities's largest Q3 2020 buy was Nuveen Dynamic Municipal Opportunities Fund: 339,000 shares worth $5.08M.
  • Wedbush Securities added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2020, an estimated $7.89M increase.
  • Wedbush Securities's biggest Q3 2020 reduction was Apple, cutting an estimated $16.5M.
  • Wedbush Securities fully exited Invesco KBW High Dividend Yield Financial ETF in Q3 2020, selling an estimated $810K.
  • Wedbush Securities's ten largest holdings make up 20% of its $1.04B portfolio in Q3 2020.
  • Wedbush Securities opened 108 new positions and closed 137 in Q3 2020.
  • Wedbush Securities's portfolio value fell 1.4% quarter-over-quarter to $1.04B.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.